Education
About Us
Working with TipRanks
Follow Us
GeneDx Holdings (WGS)
NASDAQ:WGS
Total Valuation
GeneDx Holdings has a market cap or net worth of $2.28B. The enterprise value is $2.33B.
Market Cap$2.28B
Enterprise Value$2.33B
Share Statistics
GeneDx Holdings has 29,288,738 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,288,738
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
GeneDx Holdings’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -2.50%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-2.50%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee427.54K
Profits Per Employee-21.02K
Employee Count1,000
Asset Turnover0.75
Inventory Turnover9.27
Valuation Ratios
The current PE Ratio of GeneDx Holdings is ―. GeneDx Holdings’s PEG ratio is 2.67.
PE Ratio―
PS Ratio8.18
PB Ratio11.35
Price to Fair Value11.35
Price to FCF245.23
Price to Operating Cash Flow62.85
PEG Ratio2.67
Income Statement
In the last 12 months, GeneDx Holdings had revenue of 427.54M and earned -21.02M in profits. Earnings per share was -0.73.
Revenue427.54M
Gross Profit298.17M
Operating Income-11.80M
Pretax Income-21.14M
Net Income-21.02M
EBITDA6.63M
Earnings Per Share (EPS)-0.73
Cash Flow
In the last 12 months, operating cash flow was 33.28M and capital expenditures -19.02M, giving a free cash flow of 14.26M billion.
Operating Cash Flow33.28M
Free Cash Flow14.26M
Free Cash Flow per Share0.49
Dividends & Yields
GeneDx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change-17.66%
50-Day Moving Average97.55
200-Day Moving Average111.07
Relative Strength Index (RSI)40.22
Average Volume (3m)795.84K
Important Dates
GeneDx Holdings upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateFeb 23, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
GeneDx Holdings as a current ratio of 2.46, with Debt / Equity ratio of 49.30%
Current Ratio2.46
Quick Ratio2.34
Debt to Market Cap0.03
Net Debt to EBITDA7.09
Interest Coverage Ratio-4.65
Taxes
In the past 12 months, GeneDx Holdings has paid -116.00K in taxes.
Income Tax-116.00K
Effective Tax Rate<0.01
Enterprise Valuation
GeneDx Holdings EV to EBITDA ratio is 534.93, with an EV/FCF ratio of 248.52.
EV to Sales8.29
EV to EBITDA534.93
EV to Free Cash Flow248.52
EV to Operating Cash Flow106.51
Balance Sheet
GeneDx Holdings has $171.28M in cash and marketable securities with $151.95M in debt, giving a net cash position of $19.34M billion.
Cash & Marketable Securities$171.28M
Total Debt$151.95M
Net Cash$19.34M
Net Cash Per Share$0.66
Tangible Book Value Per Share$4.69
Margins
Gross margin is 68.49%, with operating margin of -2.76%, and net profit margin of -4.92%.
Gross Margin68.49%
Operating Margin-2.76%
Pretax Margin-4.94%
Net Profit Margin-4.92%
EBITDA Margin1.55%
EBIT Margin-4.35%
Analyst Forecast
The average price target for GeneDx Holdings is $154.13, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$154.13
Price Target Upside98.16% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast50.50%
EPS Growth Forecast―